Responses
Clinical/translational cancer immunotherapy
Original research
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Compose a Response to This Article
Other responses
No responses have been published for this article.